Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 49 条
  • [31] Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP
    Kang, Junho
    Chae, Heejung
    Hong, Jung Yong
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Lee, Sang Wook
    Park, Chan Sik
    Ryu, Jin-Sook
    Huh, Jooryung
    Suh, Cheolwon
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1119 - 1125
  • [32] The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent
    Kocher, Florian
    Mian, Michael
    Seeber, Andreas
    Fiegl, Michael
    Stauder, Reinhard
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [33] Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP
    Umino, Kento
    Fujiwara, Shin-Ichiro
    Minakata, Daisuke
    Yamamoto, Chihiro
    Meguro, Akiko
    Matsuyama, Tomohiro
    Sato, Kazuya
    Ohmine, Ken
    Izumi, Tohru
    Muroi, Kazuo
    Kanda, Yoshinobu
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 734 - 741
  • [34] PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
    Wang, Jinfeng
    Shang, Song
    Li, Junjun
    Deng, Hongyu
    Ouyang, Linda
    Xie, Hailong
    Zhu, Haizhen
    Li, Yajun
    Zuo, Chaohui
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4999 - 5008
  • [35] Attenuated Antibody Reaction for the Primary Antigen but not for the Recall Antigen of Influenza Vaccination in Patients with Non-Hodgkin B-Cell Lymphoma after the Administration of Rituximab-CHOP
    Takata, Tohru
    Suzumiya, Junji
    Ishikawa, Takahiko
    Takamatsu, Yasushi
    Ikematsu, Hideyuki
    Tamura, Kazuo
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2009, 49 (01) : 9 - 13
  • [36] Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study
    Wieringa, Andre
    Boslooper, Karin
    Hoogendoorn, Mels
    Joosten, Peter
    Beerden, Tim
    Storm, Huib
    Kibbelaar, Robby E.
    Veldhuis, Gerrit J.
    van Kamp, Harmen
    van Rees, Bastiaan
    Kluin-Nelemans, Hanneke C.
    Veeger, Nic J. G. M.
    van Roon, Eric N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) : 489 - 496
  • [37] Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis
    Yamauchi, Takahiro
    Tasaki, Toshiki
    Tai, Katsunori
    Ikegaya, Satoshi
    Takagi, Kazutaka
    Negoro, Eiju
    Kishi, Shinji
    Yoshida, Akira
    Iwasaki, Hiromichi
    Ueda, Takanori
    ONCOLOGY LETTERS, 2015, 9 (02) : 851 - 856
  • [38] High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy
    Choi, Yong Won
    Ahn, Mi Sun
    Choi, Jin-Hyuk
    Lee, Hyun Woo
    Kang, Seok Yun
    Jeong, Seong Hyun
    Park, Joon Seong
    Han, Jae Ho
    Kim, Jang-Hee
    Sheen, Seung Soo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 210 - 218
  • [39] Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP
    Song, Guoqi
    Song, Guorong
    Ni, Huiyun
    Gu, Ling
    Liu, Hong
    Chen, Baoan
    He, Bangshun
    Pan, Yuqin
    Wang, Shukui
    Cho, William C.
    CURRENT CANCER DRUG TARGETS, 2014, 14 (07) : 659 - 670
  • [40] Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial
    Kuhnl, A.
    Cunningham, D.
    Counsell, N.
    Hawkes, E. A.
    Qian, W.
    Smith, P.
    Chadwick, N.
    Lawrie, A.
    Mouncey, P.
    Jack, A.
    Pocock, C.
    Ardeshna, K. M.
    Radford, J.
    McMillan, A.
    Davies, J.
    Turner, D.
    Kruger, A.
    Johnson, P. W.
    Gambell, J.
    Rosenwald, A.
    Ott, G.
    Horn, H.
    Ziepert, M.
    Pfreundschuh, M.
    Linch, D.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1540 - 1546
12345